Search

1. Buprenorphine: an overview for clinicians

Author(s):

Steiger, Scott, author
DeFries, Triveni, author

Publication:

[Oakland, California] : California Health Care Foundation, August 2019

Subject(s):

Buprenorphine -- therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
California
United States

2. The consistently low percentage of Medicare enrollees receiving medication to treat their opioid use disorder remains a concern

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2023

Subject(s):

Government Regulation
Medicare
Opiate Overdose -- prevention & control
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

3. Digital health technologies as an adjunct to medication assisted therapy for opioid use disorder: final evidence report and meeting summary

Author(s):

Tice, Jeffrey A., author
Whittington, Melanie D., author
Fluetsch, Noemi, author
Zapata, Lorenzo Villa, author
Mendola, Nicolas D., author
Chapman, Rick M., author
Campbell, Jonathan D., author
Pearson, Steven D., author
Bradt, Pamela, author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, December 11, 2020

Subject(s):

Behavior Therapy
Digital Technology
Opiate Substitution Treatment
Opioid-Related Disorders -- therapy
United States

4. Extended-release opioid agonists and antagonist medications for addiction treatment (MAT) in patients with opioid use disorder: effectiveness and value : final evidence report

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, December 3, 2018

Subject(s):

Analgesics, Opioid -- therapeutic use
Narcotic Antagonists -- therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

5. Flexibilities in controlled substances prescribing and dispensing during the COVID-19 pandemic

Publication:

Washington, D.C. : Assistant Secretary for Planning and Evaluation, Office of Science & Data Policy, August 2022

Subject(s):

Controlled Substances -- supply & distribution
COVID-19
Electronic Prescribing
Federal Government
Health Services Accessibility
Opiate Substitution Treatment
State Government
United States

6. Geographic disparities affect access to buprenorphine services for opioid use disorder

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, January 2020

Subject(s):

Buprenorphine -- supply & distribution
Health Services Accessibility
Medically Underserved Area
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States
United States. Department of Health and Human Services
United States. Substance Abuse and Mental Health Services Administration

7. How community health centers are addressing the opioid epidemic: case study

Author(s):

Hayes, Robert M., author
Squitieri, Joseph, author

Publication:

New York, NY : Milbank Memorial Fund, April 2019

Subject(s):

Child of Impaired Parents
Community Health Centers
Community Health Services
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

8. Increasing access to medications for opioid use disorder: policy strategies during and after COVID-19 pandemic

Author(s):

Au-Yeung, Caroline M., author
Blewett, Lynn A., author
Winkelman, Tyler N.A., author

Publication:

New York, NY : Milbank Memorial Fund, October 2021

Subject(s):

Health Services Accessibility
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Buprenorphine -- therapeutic use
COVID-19
Health Policy
Methadone -- therapeutic use
Naltrexone -- therapeutic use
United States

9. Learning from COVID-19: how pandemic-era policies for methadone prescribing could improve opioid treatment

Author(s):

Suen, Leslie W., author
Nguyen, Oanh K., author
Knight, Kelly Ray, 1969- author

Publication:

[Oakland, California] : California Health Care Foundation, April 2022

Subject(s):

COVID-19
Methadone -- therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Drug Prescriptions
Health Policy
California

10. Lowering the barriers to medication treatment for people with opioid use disorder: evidence for a low-threshold approach

Author(s):

Aronowitz, Shoshana V., author
Behrends, Czarina Navos, author
Lowenstein, Margaret, author
Schackman, Bruce, author
Weiner, Janet, author

Publication:

Philadelphia, PA : Leonard Davis Institute of Health Economics, January 2022

Subject(s):

Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Health Services Accessibility
United States

11. MAT for hospitalized patients

Author(s):

Newman, Sandra, author

Publication:

[Oakland, California] : California Health Care Foundation, June 2019

Subject(s):

Hospitalization
Inpatients
Insurance, Health, Reimbursement
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
California
United States

12. MAT for opioid use disorder: overcoming objections

Author(s):

Strugar-Fritsch, Donna, author

Publication:

[Oakland, California] : California Health Care Foundation, August 2019

Subject(s):

Buprenorphine -- therapeutic use
Health Knowledge, Attitudes, Practice
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
California
United States

13. MAT in the emergency department: FAQ

Author(s):

Newman, Sandra, author

Publication:

[Oakland, California] : California Health Care Foundation, March 2019

Subject(s):

Emergency Medical Services
Emergency Service, Hospital
Insurance, Health, Reimbursement
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Substance-Related Disorders -- drug therapy
California
United States

14. Many Medicaid enrollees with opioid use disorder were treated with medication: however, disparities present concerns

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2023

Subject(s):

Ethnic and Racial Minorities -- statistics & numerical data
Government Regulation
Health Inequities
Healthcare Disparities
Medicaid
Morphinans -- supply & distribution
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

15. Opioid use decreased in Medicare Part D, while medication-assisted treatment increased

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2019

Subject(s):

Analgesics, Opioid -- therapeutic use
Medicare Part D
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

16. Opioid use disorder: barriers to Medicaid beneficiaries' access to treatment medications : report to Congressional committees

Publication:

Washington, DC : United States Government Accountability Office, January 2020

Subject(s):

Analgesics, Opioid -- supply & distribution
Analgesics, Opioid -- therapeutic use
Health Services Accessibility
Medicaid -- economics
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States
Centers for Medicare & Medicaid Services (U.S.)

17. Opioid use disorder: treatment with injectable and implantable buprenorphine : report to Congressional committees

Publication:

Washington, DC : United States Government Accountability Office, August 2020

Subject(s):

Buprenorphine -- therapeutic use
Government Regulation
Opiate Substitution Treatment
Opioid-Related Disorders -- therapy
Substance Withdrawal Syndrome -- therapy
United States

18. Opioid use disorders: HHS needs measures to assess the effectiveness of efforts to expand access to medication-assisted treatment : report to majority leader, U.S. Senate

Publication:

Washington, DC : United States Government Accountability Office, October 2017

Subject(s):

Health Services Accessibility
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Outcome Assessment, Health Care
United States
United States. Department of Health and Human Services

19. The risk of misuse and diversion of buprenorphine for opioid use disorder in Medicare Part D continues to appear low: 2022

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2023

Subject(s):

Buprenorphine
Drug Users -- statistics & numerical data
Government Regulation
Medicare Part D -- economics
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Prescription Drug Diversion -- statistics & numerical data
United States

20. Substitutes for opium in chronic diseases

Author(s):

Adams, J. F. Alleyne (James Forster Alleyne), 1844-1914, author

Publication:

Philadelphia : Wm. J. Dornan, Printer, 1889

Subject(s):

Opiate Substitution Treatment
Chronic Disease -- drug therapy
Opium -- adverse effects
Opium Dependence -- prevention & control

21. Substitution: Damit hab ich HIV

Publication:

[Berlin] : Deutsche AIDS-Hilfe, 2011

Subject(s):

HIV Infections -- prevention & control
Acquired Immunodeficiency Syndrome -- prevention & control
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy

22. Substitution: Meine Chance für Ausbildung und Beruf

Publication:

[Berlin] : Deutsche AIDS-Hilfe, 2011

Subject(s):

Opioid-Related Disorders -- drug therapy
Acquired Immunodeficiency Syndrome -- prevention & control
HIV Infections -- prevention & control
Opiate Substitution Treatment

23. Telehealth MAT

Publication:

[Oakland, California] : California Health Care Foundation, June 2019

Subject(s):

Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Telemedicine
California
United States

24. Why health plans should go to the "MAT" in the fight against opioid addiction

Author(s):

Elitzer, Julia, author
Tatar, Margaret, author

Publication:

[Oakland, Calif.] : California Health Care Foundation, September 2017

Subject(s):

Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- prevention & control
California
United States